BirchBioMed Inc. Announces Positive Topline Data from Phase 2 Study of FS2 for Treatment of Keloid Scars

a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;}.prntac{TEXT-ALIGN: CENTER}   Canada NewsWire Topical FS2 shows statistically significant improvement versus the market leader VANCOUVER, BC,Jan. 22, 2021/CNW/ –

Read more

MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® – Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio

a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;}.prngen2{BORDER-TOP-COLOR:; VERTICAL-ALIGN: BOTTOM; BORDER-LEFT-COLOR:; BORDER-BOTTOM-COLOR:; PADDING-LEFT:0.50em; BORDER-RIGHT-COLOR:; PADDING-RIGHT:0.50em}.prnbcc{BORDER-TOP-COLOR:; BORDER-COLLAPSE: COLLAPSE; BORDER-LEFT-COLOR:; BORDER-BOTTOM-COLOR:; BORDER-RIGHT-COLOR:}   Canada NewsWire MedSkin Solutions Dr. Suwelack

Read more

Health Canada Approves BAVENCIO® for the Maintenance Treatment of Patients with Advanced Bladder Cancer

a.prnews_a{color:blue;}li.prnews_li{font-size:8pt;font-family:”Arial”;color:black;}p.prnews_p{font-size:0.62em;font-family:”Arial”;color:black;margin:0in;}.prngen2{BORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em}.prntac{TEXT-ALIGN: CENTER}.prnsbt0{BORDER-TOP:0pt}.prnbcc{BORDER-COLLAPSE: COLLAPSE}.prnsbl0{BORDER-LEFT:0pt}.prnsbb0{BORDER-BOTTOM:0pt}.prnsbr0{BORDER-RIGHT:0pt}   Canada NewsWire BAVENCIO is the first and

Read more